Laboratory-documented performance, widely deployed
ADB performance claims are tied to third-party laboratory testing under defined conditions, expert review, and more than 1,000 U.S. installations since 2008. Real-world results vary with facility conditions.
Comparative airborne reduction after 1 minute in cited test
Surface bacteria reduction in 30-minute comparison test
U.S. installations since 2008
Research studies reviewed by Dr. Ereth
"After an extensive review of over 40 research studies, it appears that PathogenFocus ADB's near-instantaneous inactivation of pathogens in breathing-zone air, and the corresponding significant reduction in bioburden, make this technology an innovative and important asset to any facility with stringent biosafety/biosecurity requirements."
Mark H. Ereth, MD
Emeritus Professor, Mayo Clinic College of Medicine and Science
Outcomes across sectors
The same technology supports different operational goals depending on the environment, from food safety programs to occupied healthcare spaces.
Food & beverage processing
Supports sanitation and food-safety programs with continuous treatment in occupied processing areas. Organism and shelf-life language should reference the applicable study.
Healthcare & long-term care
Adds continuous microbial treatment in occupied patient and staff areas as a complement to existing environmental cleaning, ventilation, and infection-prevention programs.
Education
Treats classrooms, cafeterias, and dorms during normal occupancy without interrupting the school day.
Agriculture & horticulture
Addresses mold, ethylene, and decay microorganisms in cited crop-specific and facility-specific studies from field to cold storage.
Third-party validation, head to head
ADB was tested by an independent laboratory against bipolar ionization, photocatalytic oxidation, and UVC in a controlled 2,640-cubic-foot chamber.
- AOAC, BAM, and Response Surface Methodology protocols
- Samples run in triplicate for statistical confidence
- Full validation and case-study documentation available on request
Comparative airborne reduction in one minute
2,640 ft³ chamber, third-party labIndependent third-party comparison in a 2,640-cubic-foot chamber after one minute. PathogenFocus MDBD achieved a 7.74-log reduction, reported as 99.99998%. Real-world results vary with facility conditions. Bars use a perceptual scale for legibility.
Request validation reports for your industry
Ask our team for the case studies and validation reports most relevant to your facility use and contamination-control objective.